Kenneth A. Burdick, a director of LifeStance Health Group, Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 66,589 shares of common stock through Fidelity Brokerage Services LLC on NASDAQ:LFST.
Key Highlights
- Proposed sale size: 66,589 shares of LifeStance Health Group common stock with an aggregate market value of $959,715.86, according to the filing.
- Approximate sale date: The filing lists November 9, 2026 as the approximate date of sale.
- Source of shares: The shares were acquired via restricted stock vesting from the issuer, with 11,386 shares vesting on March 7, 2025 and 55,203 shares vesting on March 8, 2025, the filing states.
- Shares outstanding: The filing reports 380,190,724 shares of common stock outstanding at the time of the notice.
- Prior sales: According to the filing, Burdick sold 500,000 shares on August 11, 2026, with gross proceeds of $5,756,737.55.
- Broker: Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield, RI 02917, is named as the broker for the proposed transaction.
LifeStance Director's Proposed Share Sale: Filing Details
Kenneth A. Burdick, identified in the filing as a director of LifeStance Health Group, Inc. (NASDAQ:LFST), submitted a Form 144 notice dated November 9, 2026, covering a proposed sale of 66,589 shares of the company's common stock. The filing lists an aggregate market value of $959,715.86 for the proposed sale. The issuer's address is listed as 4800 N. Scottsdale Road, Suite 2500, Scottsdale, Arizona 85251, with an SEC file number of 001-40478.
According to the filing, the shares proposed for sale were acquired through two restricted stock vesting events, both classified as compensation from the issuer. A tranche of 11,386 shares vested on March 7, 2025, and a second tranche of 55,203 shares vested on March 8, 2025. The filing notes that neither acquisition involved a gift or deferred payment.
The filing also discloses Burdick's sales activity during the prior three months. Per the form, he sold 500,000 shares on August 11, 2026, generating gross proceeds of $5,756,737.55. The notice was signed by Wade Moss, described as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Kenneth Burdick. The filer's representation, as stated in the form, is that he "does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed."
What Was Disclosed
A Form 144 notice was filed on November 9, 2026 by LifeStance Health Group director Kenneth A. Burdick, disclosing a proposed sale of 66,589 shares of common stock with an aggregate market value of $959,715.86, acquired through restricted stock vesting in March 2025.




Please wait processing your request...